Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 11, 2006
Process economics of industrial monoclonal antibody manufacture
Suzanne S Farid
Biotechnology Journal
|
February 8, 2019
Integrated Continuous Biomanufacturing: Industrialization on the Horizon
Suzanne S Farid
Advances in Biochemical Engineering/Biotechnology
|
September 23, 2006
Established bioprocesses for producing antibodies as a basis for future planning
Suzanne S Farid
Biotechnology Journal
|
November 24, 2020
Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates
Christos Stamatis, Suzanne S Farid
Biotechnology Journal
|
December 20, 2014
Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies
Michael J Jenkins, Suzanne S Farid
Biotechnology Progress
|
April 23, 2008
Strategic biopharmaceutical portfolio development: an analysis of constraint-induced implications
Edmund D George, Suzanne S Farid
Biotechnology and Bioengineering
|
April 1, 2021
End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies
Hanna Mahal, Harvey Branton, Suzanne S Farid
Biotechnology Progress
|
April 29, 2009
Windows of operation for bioreactor design for the controlled formation of tissue-engineered arteries
Spyridon Gerontas, Suzanne S Farid, Michael Hoare
Biotechnology and Bioengineering
|
July 12, 2024
Special Issue on "Recovery of Biological Products: Past, Present, Future"
Suzanne S Farid, Nihal Tugcu, Arne Staby
Mabs
|
December 9, 2014
Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK
Suzanne S Farid, Bill Thompson, Andrew Davidson
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 11, 2006
Process economics of industrial monoclonal antibody manufacture
Suzanne S Farid
Biotechnology Journal
|
February 8, 2019
Integrated Continuous Biomanufacturing: Industrialization on the Horizon
Suzanne S Farid
Advances in Biochemical Engineering/Biotechnology
|
September 23, 2006
Established bioprocesses for producing antibodies as a basis for future planning
Suzanne S Farid
Biotechnology Journal
|
November 24, 2020
Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates
Christos Stamatis, Suzanne S Farid
Biotechnology Journal
|
December 20, 2014
Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies
Michael J Jenkins, Suzanne S Farid
Biotechnology Progress
|
April 23, 2008
Strategic biopharmaceutical portfolio development: an analysis of constraint-induced implications
Edmund D George, Suzanne S Farid
Biotechnology and Bioengineering
|
April 1, 2021
End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies
Hanna Mahal, Harvey Branton, Suzanne S Farid
Biotechnology Progress
|
April 29, 2009
Windows of operation for bioreactor design for the controlled formation of tissue-engineered arteries
Spyridon Gerontas, Suzanne S Farid, Michael Hoare
Biotechnology and Bioengineering
|
July 12, 2024
Special Issue on "Recovery of Biological Products: Past, Present, Future"
Suzanne S Farid, Nihal Tugcu, Arne Staby
Mabs
|
December 9, 2014
Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK
Suzanne S Farid, Bill Thompson, Andrew Davidson
Page
of 6